18-Sep-2026
Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Business Wire (Mon, 14-Sep 6:45 AM ET)
Phreesia Schedules Q2 2027 Earnings Release—Quarterly Call Set for September 2
Market Chameleon (Fri, 7-Aug 4:23 AM ET)
Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
Business Wire (Thu, 6-Aug 4:06 PM ET)
Globe Newswire (Wed, 29-Jul 9:39 AM ET)
Business Wire (Thu, 23-Jul 6:51 AM ET)
MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider
Business Wire (Tue, 21-Jul 6:50 AM ET)
PRNewswire (Thu, 16-Jul 10:00 AM ET)
Newsfile (Mon, 13-Jul 12:19 PM ET)
Globe Newswire (Mon, 13-Jul 12:12 PM ET)
Business Wire (Mon, 13-Jul 9:17 AM ET)
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of September 18, 2026, PHR stock price declined to $10.04 with 1,389,944 million shares trading.
PHR has a beta of 0.97, meaning it tends to be less sensitive to market movements. PHR has a correlation of 0.04 to the broad based SPY ETF.
PHR has a market cap of $620.21 million. This is considered a Small Cap stock.
Last quarter Phreesia reported $129 million in Revenue and $.03 earnings per share. This beat revenue expectation by $339,344 and missed earnings estimates by -$.25.
In the last 3 years, PHR traded as high as $32.76 and as low as $7.77.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): VTI, IWM, VXF, FESM, SFLO.
PHR has underperformed the market in the last year with a price return of -58.5% while the SPY ETF gained +16.8%. However, in the short term, PHR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.0% vs +2.3% return in SPY. But in the last 2 weeks, PHR shares have been beat by the market, returning -8.2% compared to an SPY return of -0.9%.
PHR support price is $10.01 and resistance is $10.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.